£
Donate
Donate

Trial Treat Beat

Right now, only 1 in 3 people with the deadliest blood cancers will survive. But we have a £25 million plan to help change the odds and double survival chances. Help fund the research to make it happen.

  • Registered charity
  • Secure payment
  • 100% to mission
  • Only 1 in 3

    people survive the deadliest blood cancers.

  • ~50%

    of all blood cancer deaths are caused by the deadliest blood cancers.

  • ~40,000

    people will die of the deadliest blood cancers in the next five years

What is Trial Treat Beat?

Trial Treat Beat is our £25 million mission to double survival chances for people with the deadliest blood cancers. It’s based on a model that improved survival in prostate cancer and it’s the best chance we have to change the odds and save more lives.

The £25 million we raise will fund three innovative, large-scale clinical trials, such as MAMS trials, that will each test several treatment approaches – making them faster and more efficient. More importantly, they impact patients sooner. Because treatments which aren’t working can be stopped early, while promising treatments move forward more quickly.

£1 million of the £25 million will go to our Clinical Trials Navigation Service, to help people find relevant trials and understand what’s involved, and our Policy and Advocacy work, so that we help ensure that everyone with blood cancer has fair access to treatments when they’re available.

Find out more about MAMS trials

Where we are right now

£12.4m raised of £25m goal 51% to go

Every donation brings us closer to funding the trials that will help double survival chances.

Fund a breakthrough
Viviana speaking about Trial Treat Beat

Trial Treat Beat is really exciting. Because there might not be treatments for me, I might run out of treatments. But there might be a clinical trial that I respond really well to and I could be here for another ten years. That is really hopeful.

- Viviana, living with myeloma

Your gift today funds hope for tomorrow

Help researchers get their trials off the ground, find new treatments and accelerate progress.

Our transformational partner Omaze

We're proud to work alongside our transformational partner Omaze to deliver the first clinical trial for Trial Treat Beat. Their support helps us increase awareness of clinical trials, fund vital research, and improve outcomes for people affected by blood cancer.

Got any questions?

Explore our frequently asked questions for guidance and useful information.